Navigation Links
Scientists Hot on Trail of New Antibiotics
Date:10/17/2008

Natural compounds could mean faster treatments for TB, fight other drug-resistant bacteria

FRIDAY, Oct. 17 (HealthDay News) -- Researchers believe they are close to perfecting a new class of broad-spectrum antibiotics that could counter increasingly drug-resistant bacteria, a new study says.

The new antibiotics compounds -- all of which are natural products produced by certain bacteria to battle other bacteria -- also show promise as a more effective and faster treatment for tuberculosis. One in three people worldwide carries TB, and today's antibiotics are not efficient in combating it.

The new research, published in the Oct. 17 issue of the journal Cell, is encouraging, because bacterial infectious diseases are responsible for a quarter of all deaths worldwide. For all major bacterial pathogens, strains resistant to at least one current antibiotic have arisen, according to one researcher.

"For six decades, antibiotics have been our bulwark against bacterial infectious diseases," Richard Ebright, a Howard Hughes Institute investigator at Rutgers University, said in an interview issued by the journal's publisher. "Now, this bulwark is collapsing. There is an urgent need for new antibiotic compounds and practical new targets."

The new antibiotic compounds under study are myxopyronin, corallopyronin, and ripostatin. They block the action in bacteria of RNA polymerase, an essential protein in all organisms that is necessary to transcribe the genetic instructions in DNA into RNA, which in turn directs the assembly of proteins.

"RNA polymerase has a shape reminiscent of a crab claw, with two prominent pincer-like projections," Ebright said. "Just as with a real crab claw, one pincer stays fixed and one pincer moves, opening and closing to keep DNA in place. The pincer that moves does so by rotating about a hinge. Our studies show that the three antibiotics bind to and jam this hinge."

"It's an amazing site," Eddy Arnold, also of Rutgers University, said of this hinge that the researchers refer to as a switch region. "It's a drug designer's dream, because it's a pocket that can accommodate a variety of chemical inhibitors."

Myxopyronin and corallopyronin appear to work against a broad range of infectious diseases including TB, according to the researchers. The current treatment for TB, rifamycins, requires six months to two years of therapy, depending on whether the person can tolerate the drugs or whether the strain of TB the person has is resistant to antibiotics.

The researchers said that antibiotics targeting this RNA polymerase hinge cut treatment time down to as little as two weeks.

More information

The American Lung Association has more about tuberculosis.



-- Kevin McKeever



SOURCE: Cell Press, news release, Oct. 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New prion protein discovered by Canadian scientists may offer insight into mad cow disease
2. Scientists Probe Sepsis Deadly Secrets
3. Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
4. Scientists Develop Natural Protection for Stored Foods
5. Scientists detect presence of marburg virus in african fruit bats
6. Scientists Spot Brains Free Will Center
7. Scientists ID Likely Culprit in Popcorn Lung
8. Scientists explain how insulin secreting cells maintain their glucose sensitivity
9. Scripps Research scientists shed new light on how antibodies fight HIV
10. Scientists, physicians present latest findings in personalized cancer treatment and prevention
11. Scientists demonstate link between genetic variant and effectiveness of smoking cessation meds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scientists Hot on Trail of New Antibiotics
(Date:10/13/2017)... WI (PRWEB) , ... October 13, 2017 , ... As ... in medicine known as “patient engagement.” The patient is doing more than filling out ... partners. , “There is an increasing emphasis in health care and research on ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... certification process to promote standards of excellence for the field of eating disorders, ... March 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the Law ... organization of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our ... a forum to network with elder law attorneys nationwide,” said Somekh. , ...
(Date:10/13/2017)... ... ... The Visiting Nurse Association (VNA) of Somerset Hills is proud to host ... items from across the nation, this holiday-themed event will raise funds and awareness for ... The boutique will be open Saturday, November 4 (10:00 a.m. – 5:00 p.m.) ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... the most popular and least understood books in the Holy Scriptures, Revelation. The Book ... have baffled scholars for centuries. Many have tossed it off as mere rubbish, but ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... ALLENTOWN , Pa. and KALAMAZOO, Mich. ... Allentown, Penn. , and OptiMed Specialty Pharmacy ... a business partnership to offer a strategic hub service ... PMD Healthcare,s highly sought-after personal spirometer, Spiro PD 2.0, ... A spirometer is a medical device used ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis ... global supply chains, has published the first annual edition of its Global ... more than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that ... ... Risk & Performance Index ...
(Date:9/9/2017)... -- ... Washington DC ... 12 th – Monday, September 18 th .The Brain Tumor Foundation ... scans to the public.Where:  BTF,s Mobile MRI Unit ... Street NW, Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early ...
Breaking Medicine Technology: